Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
PBYI - Puma Biotechnology Inc
Market Cap 168.61M P/E 32.82 EPS this Y -42.20% Ern Qtrly Grth -
Income 21.59M Forward P/E 18.05 EPS next Y -34.60% 50D Avg Chg 6.00%
Sales 235.64M PEG 0.08 EPS past 5Y - 200D Avg Chg 3.00%
Dividend N/A Price/Book 6.52 EPS next 5Y 232.50% 52W High Chg -30.00%
Recommedations 3.00 Quick Ratio 1.45 Shares Outstanding 48.21M 52W Low Chg 74.00%
Insider Own 15.12% ROA 9.19% Shares Float 29.40M Beta 1.31
Inst Own 66.58% ROE 57.54% Shares Shorted/Prior 3.33M/3.33M Price 3.61
Gross Margin 73.40% Profit Margin 9.16% Avg. Volume 216,567 Target Price 4.33
Oper. Margin 21.37% Earnings Date May 2 Volume 122,028 Change 1.69%
Healthcare | Biotechnology | United States
About Puma Biotechnology Inc

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Puma Biotechnology Inc News
04/18/24 Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
04/08/24 Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
04/03/24 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/22/24 Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
03/22/24 Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
03/20/24 Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
03/05/24 FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
03/04/24 J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
03/02/24 Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript
03/02/24 Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimate
03/01/24 Q4 2023 Puma Biotechnology Inc Earnings Call
03/01/24 Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term
03/01/24 Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates
03/01/24 Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
02/29/24 Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023
02/29/24 Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
02/29/24 Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y
02/29/24 Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
02/27/24 Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4
02/27/24 Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
PBYI Chatroom

User Image biovalidator Posted - 7 hours ago

$PBYI ASCO conference puma

User Image biovalidator Posted - 8 hours ago

$PBYI bullish for cc

User Image jacky1230 Posted - 1 day ago

$PBYI 5.5

User Image Cinderella74 Posted - 1 day ago

$PBYI

User Image StockConsultant Posted - 2 days ago

$PBYI Puma Biotechnology stock at 5.15 support area, attempting to trend higher

User Image Fullratio Posted - 3 days ago

Healthcare sector stocks with high EPS growth in Q4 2023 (TTM): $LIVN $PBYI $RPRX

User Image Cinderella74 Posted - 6 days ago

$PBYI slowly but surely going to the basement

User Image Stock_Titan Posted - 1 week ago

$PBYI Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results https://www.stocktitan.net/news/PBYI/puma-biotechnology-to-host-conference-call-to-discuss-first-quarter-940uug1zsg3g.html

User Image Academia Posted - 1 week ago

$NVAX $PBYI If I showed the gain, they'd claim it wasn't real. How you bulls holding up?

User Image Gius_me Posted - 1 week ago

$PBYI laughing and joking…we are closed to the trial

User Image Rob997 Posted - 1 week ago

$PBYI Hey @bbtb what else bad can happen to this company ? ))))

User Image Rob997 Posted - 1 week ago

$PBYI https://casetext.com/case/puma-biotechnology-inc-v-astrazeneca-pharm-1

User Image Jonnyking Posted - 2 weeks ago

$PBYI she went back to 6 today, 7 next.

User Image PSDL75 Posted - 2 weeks ago

$PBYI @Jonnyking you sell my man?

Analyst Ratings
HC Wainwright & Co. Buy Mar 1, 24
HC Wainwright & Co. Buy Feb 13, 24
HC Wainwright & Co. Buy Sep 20, 23
HC Wainwright & Co. Buy Aug 4, 23
HC Wainwright & Co. Buy Jun 5, 23
HC Wainwright & Co. Buy May 5, 23
HC Wainwright & Co. Buy Mar 6, 23
HC Wainwright & Co. Buy Aug 5, 22
HC Wainwright & Co. Buy May 6, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Dec 04 Sell 3.7608 280 1,053 97,934 01/10/24
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jan 03 Sell 4.4859 7,733 34,689 98,214 01/05/24
Ludwig Jeffrey Jerome Chief Commercial Off.. Chief Commercial Officer Jan 03 Sell 4.4859 12,956 58,119 99,970 01/05/24
AUERBACH ALAN H President and CEO President and CEO Jan 03 Sell 4.4859 41,396 185,698 6,936,947 01/05/24
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jan 03 Sell 4.4859 15,682 70,348 128,666 01/05/24
HUNT DOUGLAS M See Remarks See Remarks Jan 03 Sell 4.4859 8,358 37,493 103,319 01/05/24
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jul 03 Sell 3.3112 6,938 22,973 105,947 07/06/23
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jul 03 Sell 3.3112 14,680 48,608 144,348 07/06/23
Ludwig Jeffrey Jerome Chief Commercial Off.. Chief Commercial Officer Jul 03 Sell 3.3112 12,103 40,075 112,926 07/06/23
HUNT DOUGLAS M See Remarks See Remarks Jul 03 Sell 3.3112 7,809 25,857 111,677 07/06/23
AUERBACH ALAN H President and CEO President and CEO Jul 03 Sell 3.3112 60,698 200,983 6,978,343 07/06/23
WILSON TROY EDWARD Director Director Jun 13 Sell 3.45 27,000 93,150 350 06/15/23
MOYES JAY M Director Director Jun 13 Sell 3.45 22,000 75,900 16,322 06/15/23
Stuglik Brian M Director Director Jun 13 Sell 3.46 9,900 34,254 31,958 06/15/23
Senderowicz Adrian Director Director Jun 13 Sell 3.45 27,000 93,150 06/15/23
Dorval Allison Director Director Jun 13 Sell 3.45 10,000 34,500 17,000 06/15/23
MILLER MICHAEL PATRICK Director Director Jun 13 Sell 3.45 13,500 46,575 41,358 06/15/23
AUERBACH ALAN H President and CEO President and CEO Jan 03 Sell 4.1779 27,241 113,810 6,852,638 01/05/23
AUERBACH ALAN H President and CEO President and CEO Dec 02 Sell 4.49780 1,251 5,627 6,311,698 12/06/22
HUNT DOUGLAS M See Remarks See Remarks Dec 02 Sell 4.49780 429 1,930 75,575 12/06/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Dec 02 Sell 4.49780 159 715 110,926 12/06/22
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Dec 02 Sell 4.49780 514 2,312 58,013 12/06/22
HUNT DOUGLAS M See Remarks See Remarks Nov 02 Sell 2.25 429 965 76,004 11/04/22
AUERBACH ALAN H President and CEO President and CEO Nov 02 Sell 2.25 1,242 2,794 6,312,949 11/04/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Nov 02 Sell 2.25 163 367 111,085 11/04/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Oct 03 Sell 2.3354 165 385 111,248 10/05/22
HUNT DOUGLAS M See Remarks See Remarks Oct 03 Sell 2.3354 435 1,016 76,433 10/05/22
AUERBACH ALAN H President and CEO President and CEO Oct 03 Sell 2.3354 1,260 2,943 6,314,191 10/05/22
MILLER MICHAEL PATRICK Director Director Aug 09 Sell 3.5517 25,000 88,792 54,858 08/10/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Aug 02 Sell 2.89 161 465 111,577 08/04/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jul 05 Sell 2.6315 9,328 24,547 111,738 08/04/22
HUNT DOUGLAS M See Remarks See Remarks Aug 02 Sell 2.89 429 1,240 77,301 08/04/22
AUERBACH ALAN H President and CEO President and CEO Aug 02 Sell 2.89 1,247 3,604 6,316,705 08/04/22
HUNT DOUGLAS M See Remarks See Remarks Jul 05 Sell 2.6315 3,753 9,876 77,730 07/07/22
AUERBACH ALAN H President and CEO President and CEO Jul 05 Sell 2.6315 26,140 68,787 6,317,952 07/07/22
Ludwig Jeffrey Jerome Chief Commercial Off.. Chief Commercial Officer Jul 05 Sell 2.6315 5,835 15,355 64,625 07/07/22
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jul 05 Sell 2.6315 2,920 7,684 58,527 07/07/22
Senderowicz Adrian Director Director Jun 16 Sell 2.6313 27,858 73,303 27,000 06/21/22
WILSON TROY EDWARD Director Director Jun 16 Sell 2.5835 27,858 71,971 27,350 06/21/22
Stuglik Brian M Director Director Jun 16 Sell 2.686 13,000 34,918 41,858 06/21/22
MOYES JAY M Director Director Jun 16 Sell 2.6411 22,858 60,370 38,322 06/21/22
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jun 02 Sell 1.9241 587 1,129 61,447 06/06/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jun 02 Sell 1.9218 162 311 121,066 06/06/22
HUNT DOUGLAS M See Remarks See Remarks Jun 02 Sell 1.9441 417 811 81,483 06/06/22
AUERBACH ALAN H President and CEO President and CEO Jun 02 Sell 1.9441 1,200 2,333 6,344,092 06/06/22
HUNT DOUGLAS M See Remarks See Remarks May 03 Sell 2.3101 438 1,012 81,900 05/05/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer May 03 Sell 2.3401 165 386 121,228 05/04/22
AUERBACH ALAN H President and CEO President and CEO May 03 Sell 2.3201 1,263 2,930 6,345,292 05/04/22
AUERBACH ALAN H President and CEO President and CEO Apr 04 Sell 3.078 1,198 3,687 6,346,555 04/05/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Apr 04 Sell 3.078 206 634 121,393 04/05/22